Navigation Links
Dipexium Pharmaceuticals Reports Second Quarter 2014 Financial and Operational Results
Date:8/12/2014

NEW YORK, Aug. 12, 2014 /PRNewswire/ -- Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late stage pharmaceutical company focused on the development and commercialization of Locilex® (pexiganan cream 0.8%), a novel, broad spectrum, topical antibiotic peptide, today reported its financial results for the second quarter ended June 30, 2014 and provided an update on operational progress.

"The first half of 2014 has been an exciting period for Dipexium. We are very pleased with the progress achieved since the completion of our Initial Public Offering in March," stated David P. Luci, President & Chief Executive Officer of Dipexium. "Importantly, we remain on our stated timeline to complete enrollment in the OneStep-1 and OneStep-2 pivotal Phase 3 clinical trials in the first quarter of 2015 and file a New Drug Application (NDA) for Locilex® in the second half of 2015."

Financial Results for the Second Quarter of 2014For the three months ended June 30, 2014, Dipexium reported a net loss of approximately $3.9 million, compared to $0.4 million for the three months ended June 30, 2013, an increase of $3.5 million, primarily due to a $2.5 million increase in research and development expenses and a $1.0 million increase in general and administrative expenses. The increased research and development expenses were primarily due to an increase of $1.9 million in research and development consulting-related expenses for the planning and execution of Locilex®'s Phase 1 and 3 clinical trials and a $0.6 million increase in research and development manufacturing costs related to manufacturing Locilex® for clinical trials. The increase in general and administrative expenses is primarily attributable to an increase of $0.7 million for compensation related expenses and an increase in $0.3 million in professional fees and office expenses.

For the six months end
'/>"/>

SOURCE Dipexium Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Valeant Pharmaceuticals Receives FTC Second Request Under Hart-Scott-Rodino
2. Rock Creek Pharmaceuticals Reports Second Quarter and Announces Clinical Update
3. AcelRx Pharmaceuticals Reports Second Quarter 2014 Financial Results
4. Inovio Pharmaceuticals Reports 2014 Second Quarter Financial Results
5. Absorption Pharmaceuticals CEO Jeff Abraham Discusses Promescent on KFI
6. Global Diabetic Neuropathy Market 2014-2018: Key Vendors are Eli Lilly and Co, Janssen Pharmaceuticals and Pfizer Inc.
7. Jazz Pharmaceuticals Announces Pricing of $500 Million of Exchangeable Senior Notes
8. AcelRx Pharmaceuticals to Participate in Three Upcoming Investor Events
9. Global Transdermal Drug Delivery Market 2014-2018: Key Vendors are ANI Pharmaceuticals, Antares Pharma, Bayer, Janssen and Novartis
10. Access Pharmaceuticals Announces European License Agreement With Norgine
11. Vanda Pharmaceuticals Reports Second Quarter 2014 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... December 18, 2014 Radiology ... that is used to store, manipulate, and distribute ... a patient tracking and scheduling system, result reporting, ... RIS with HIS and other databases improves the ... and patient scheduling, patient list management, radiology department ...
(Date:12/19/2014)... , Dec. 18, 2014 Research and ... the addition of the "Micro Market Monitor: ... to their offering. ... treatment is progressing steadily, which has resulted in ... devices market. The main purpose of these dermatology ...
(Date:12/19/2014)... BURLINGTON, Mass. , Dec. 18, 2014  Decision ... the United States will increase ... Growth will be primarily driven by expansion in the ... direct energy devices will be increasingly adopted due to ... launched. Other key findings from Decision Resources ...
Breaking Medicine Technology:The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3Micro Market Monitor: North American Dermatology Diagnostic Devices Market 2Micro Market Monitor: North American Dermatology Diagnostic Devices Market 3U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 2U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 3
... Sequenom, Inc. (NASDAQ: SQNM ), a life sciences company ... results for the third quarter of 2011 after closing of the ... conference call hosted by Harry F. Hixson, Jr., Ph.D., Chairman and ... the same day at 5:00pm ET (2:00pm PT) and will be ...
... STAAR Surgical Company (NASDAQ: STAA ) ... the third quarter ended September 30, 2011. The Company ... final results on Monday, October 24, 2011 in order ... other attendees of the American Association of Ophthalmology (AAO) ...
Cached Medicine Technology:Sequenom, Inc. Announces Date of Third Quarter 2011 Financial Results and Conference Call 2STAAR Surgical Provides Outlook on Third Quarter 2011 Revenue and Cash 2STAAR Surgical Provides Outlook on Third Quarter 2011 Revenue and Cash 3STAAR Surgical Provides Outlook on Third Quarter 2011 Revenue and Cash 4STAAR Surgical Provides Outlook on Third Quarter 2011 Revenue and Cash 5
(Date:12/21/2014)... December 21, 2014 Khanna Vision Institute ... guest at the Aspen Helicopters holiday event for underprivileged ... Santa with sleigh, flown by an aspen helicopter pilot. ... only Santa with sleigh was visible.(please see accompanying video). ... night. Dr.Khanna has helped many pilots with Pi in ...
(Date:12/21/2014)... Dennis Thompson HealthDay ... Former tobacco smokers find e-cigarettes less addictive than traditional cigarettes, ... as often as they did regular cigarettes, thousands of ex-smokers ... feel impulsive and irritable over their need to smoke, researchers ... The score was significantly less for e-cig use than for ...
(Date:12/21/2014)... 2014 Serious Buyer, Andrew Hawley from ... Morrison and the Doors International Ballroom at the Hilton ... be the only time that Morrison's mother would see ... 25, 1967. According to Hawley, “This would be the ... the Alexandria Roller Rink earlier that year and would ...
(Date:12/21/2014)... 2014 Theme and plugin ... intro plugin for Final Cut Pro X entitled ProMotion. ... and more with absolute ease.” Said Christiana Austin, CEO ... tools needed to easily animate their media inside FCPX.” ... X users to animate pictures, videos, logos, and more ...
(Date:12/21/2014)... Virginia (PRWEB) December 21, 2014 Concept Plus, ... and engineering firm headquartered in Fairfax, VA., today announced ... of its Fast 50 list, which ranks the fastest growing ... rate from 2009 to 2013. , This is the first ... and it ranked # 20 with a 95.92% compound annual ...
Breaking Medicine News(10 mins):Health News:E-Cigarettes Less Addictive Than Regular Cigarettes, Study Finds 2Health News:E-Cigarettes Less Addictive Than Regular Cigarettes, Study Finds 3Health News:Announcing a new plugin for Final Cut Pro X ProMotion from Pixel Film Studios. 2Health News:Concept Plus, LLC. Named One of Washington Technology’s Fast 50 2
... than ever before,pharmaceutical sales and marketing executives are ... fill pipelines, demands for more R&D,results, and competition ... sales teams across the board., Externally, new ... continue to loom. Changes affecting the,sales and marketing ...
... 13 Sun Busters(R), the swim,wear line for children ... in sun protection now sports a new feature -- ... Busters is proud,to announce that they have met the ... a UPF of 50+. UPF is a similar concept ...
... 13 Statistics released by the,Centers for Disease Control ... children is affected by autism. In Georgia, these statistics,are ... is rising in,prevalence with alarming speed. It is estimated ... are affected by autism, a disorder of,unknown origin that ...
... WASHINGTON, Feb. 13 AdvaMed, the Advanced,Medical ... that,demonstrates the slow rate in growth in overall ... The study,s author, Roland Guy King, former chief ... found that medical technology is a,relatively small and ...
... Large Minnesota Multi-Specialty Group Automates and Connects Physicians, ... ... Minn., Feb. 13 ,Allscripts, the leading provider of clinical ... healthcare, today,announced that Mankato Clinic has selected the Allscripts ...
... die of other causes , , WEDNESDAY, Feb. 13 (HealthDay News) ... that most older men with early prostate cancer do not ... to the disease. , In fact, most such patients ... any complications from the cancer, the researchers found. , "Many ...
Cached Medicine News:Health News:Legislative and Regulatory Outlook - 2009 and Beyond for Pharma, Biotech Players 2Health News:Sun Busters(R) Now Sports The Skin Cancer Foundation's Seal of Recommendation 2Health News:Sun Busters(R) Now Sports The Skin Cancer Foundation's Seal of Recommendation 3Health News:2008 Georgia Walk for Autism Supporters Gather in Atlanta for Kick-Off Dinner 2Health News:New Study Finds Slow Rate of Growth in Overall Medical Technology Prices 2Health News:Mankato Clinic Selects Allscripts Electronic Health Record 2Health News:Mankato Clinic Selects Allscripts Electronic Health Record 3Health News:Mankato Clinic Selects Allscripts Electronic Health Record 4Health News:Many Prostate Cancers Will Not Need Treatment 2Health News:Many Prostate Cancers Will Not Need Treatment 3
... The TL-100 uses technology that takes ... by automatically detecting and reading them. It ... recording the results, mark lenses as you ... contact lenses. Easy to use, the TL-100 ...
... The Kowa RC-XV3 camera is ... The automatic exposure system, ... sensitivity, the 2.5~300ws watt indication ... handling are the basic features ...
FF 450plus fundus camera for 35mm photography. Upgradeable basic instrument for brilliant image quality....
The new TRC-NW6 non-mydriatic retinal camera is the ideal instrument for the growing market in telemedicine and diabetic screening....
Medicine Products: